Maureen Cleary

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

Joseph Muenzer, J. E. Wraith, Michael Beck et al. · Genetics in Medicine · 2006 · 578 citations · Full text

Allergy, Enzyme Replacement Therapy, Inherited Metabolic Disease +6

Diagnostic criteria for respiratory chain disorders in adults and children

François P. Bernier, Avihu Boneh, Xenia Dennett et al. · Neurology · 2002 · 571 citations

Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study

Harvey L. Levy, Andrzej Milanowski, Anupam Chakrapani et al. · The Lancet · 2007 · 307 citations

Sapropterin Dihydrochloride, Renal Function, Chronic Kidney Disease +6

Respiratory chain complex I deficiency

Denise M. Kirby, Megan Crawford, Maureen Cleary et al. · Neurology · 1999 · 264 citations

Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome

Joseph Muenzer, Michael Beck, Christine M. Eng et al. · Genetics in Medicine · 2010 · 223 citations · Full text

Autoimmune Disease, Open-labeled Extension Study, Inherited Metabolic Disease +4